Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Unknown 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Glioblastoma 11Glioma 4Sarcoma, Ewing 2Recurrence 2Medulloblastoma 2Brain Neoplasms 2Triple Negative Breast Neoplasms 1Solid Tumor Cancer 1Sarcoma 1SCLC, Extensive Stage 1Rhabdomyosarcoma 1Primary Glioblastoma 1Pancreatic Neoplasms 1Osteosarcoma 1Melanoma 1Lymphoma, Follicular 1Hypoxia 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Astrocytoma 1Advanced Glioblastoma 1

Interventions

Gemcitabine 21130-nm albumin-bound paclitaxel 8irinotecan sucrosofate 7Oxaliplatin 7Leucovorin 7Fluorouracil 7Taxes 5Drug Therapy 5Albumin-Bound Paclitaxel 4toripalimab 3Specimen Handling 3S 1 (combination) 3Paclitaxel 3Irinotecan 3Injections 3zimberelimab 2surufatinib 2camrelizumab 2Pemetrexed 2Pancreaticoduodenectomy 2Magnetic Resonance Spectroscopy 2Exercise 2Capecitabine 2Blood Specimen Collection 2Biopsy 2trastuzumab deruxtecan 1sintilimab 1semaglutide 1potassium oxonate 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Pancreatic Neoplasms × Temozolomide × Clear all
NCT07492680 2026-05-29

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Bristol-Myers Squibb

Phase 2 Not yet recruiting
260 enrolled
CNSDermatologicGastrointestinal

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡